A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population

What Is Known and Objective Traumatic brain injury (TBI) is a major cause of disability, and it has been associated with agitation and aggression. In a previous study, we reviewed the literature to identify evidence‐based pharmacological agents for treatment of agitation in TBI. Based on the results...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical pharmacy and therapeutics 2022-12, Vol.47 (12), p.2083-2090
Hauptverfasser:	Rahmani, Elham, Lemelle, Tricia, Sharp, Hunter, Smarbafzadeh, Ehsan, Kablinger, Anita
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic beta-Antagonists - therapeutic use Adult Aggression Aggression - psychology Agitation Amantadine Amantadine - therapeutic use Anticonvulsants - therapeutic use Antipsychotic Agents - therapeutic use Antipsychotics Benzodiazepines Benzodiazepines - therapeutic use Beta blockers Brain Injuries, Traumatic - complications Brain Injuries, Traumatic - drug therapy Electronic medical records Haloperidol Humans Inpatients Methylphenidate Original Patients Psychomotor Agitation - drug therapy Psychomotor Agitation - etiology Psychotropic drugs Statistical analysis Traumatic brain injury Virginia Withdrawal
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!